SCHEMBL1408561

SCHEMBL1408561

CCCCC(CC)CC(S)CC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.44
ALDH1A1 P00352 4/20 0.44
GPR84 Q9NQS5 4/20 0.42
MAPK1 P28482 1/20 0.41
CYP3A4 P08684 4/20 0.41
TSHR P16473 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
ATM Q13315 1/20 0.41
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30880214 0.84 CA2 (0.43) CA2ALDH1A1MAPK1CYP3A4TSHR
SCHEMBL29040980 0.81 CYP3A4 (0.45) CA2ALDH1A1MAPK1CYP3A4TSHR
SCHEMBL9176596 0.81 ALDH1A1 (0.54) CA2ALDH1A1GPR84MAPK1CYP3A4
SCHEMBL4440711 0.81 ALDH1A1 (0.54) CA2ALDH1A1GPR84MAPK1CYP3A4
SCHEMBL140442 0.81 ALDH1A1 (0.54) CA2ALDH1A1GPR84MAPK1CYP3A4
SCHEMBL1408668 0.81 GPR84 (0.50) CA2ALDH1A1GPR84MAPK1TSHR
SCHEMBL20549004 0.80 GPR84 (0.56) CA2ALDH1A1GPR84MAPK1CYP3A4
Hydrochloric Acid SCHEMBL10578864 0.79 ALDH1A1 (0.52) CA2ALDH1A1GPR84MAPK1CYP3A4
SCHEMBL10617533 0.79 ALDH1A1 (0.52) CA2ALDH1A1GPR84MAPK1CYP3A4
SCHEMBL8681836 0.79 ALDH1A1 (0.52) CA2ALDH1A1GPR84MAPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 585 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4606831-A1 FAST-CURING TWO-COMPONENT POLYURETHANE COMPOSITION WITH LONG POT LIFE Sika Technology AG (CH) 2025-08-27 EP claimed
US-20220119569-A1 Curable and Solvent Soluble Formulations and Methods of Making and Using Therof POLY6 TECHNOLOGIES, INC. 2022-04-21 US claimed
CN-107209454-B Embossing lacquer and embossing method and substrate surface coated with said embossing lacquer 约阿内研究有限责任公司 2021-02-02 CN claimed
CN-107206770-B Photocurable adhesive composition, its preparation and use 汉高股份有限及两合公司 2020-09-08 CN claimed
US-10717907-B2 Photo-curable adhesive composition, preparation and use thereof HENKEL AG & CO. KGAA (DE) 2020-07-21 US claimed
US-20200062877-A1 Curable and Solvent Soluble Formulations and Methods of Making and Using Therof POLY6 TECHNOLOGIES, INC. 2020-02-27 US claimed
EP-3230795-B1 EMBOSSING LACQUER AND METHOD FOR EMBOSSING JOANNEUM RES FORSCHUNGSGMBH (AT) 2019-06-05 EP claimed
WO-2018156766-A2 CURABLE AND SOLVENT SOLUBLE FORMULATIONS AND METHODS OF MAKING AND USING THEREOF POLY6 TECHNOLOGIES, INC. (US) 2018-08-30 WO claimed
CN-107206770-A Photocurable adhesive composition, its preparation and use 汉高股份有限及两合公司 2017-09-26 CN claimed
US-20170253780-A1 PHOTO-CURABLE ADHESIVE COMPOSITION, PREPARATION AND USE THEREOF HENKEL AG & CO KGAA (DE) 2017-09-07 US claimed
US-9127107-B2 Aqueous amphiphilic copolymer emulsions having controlled viscosity and methods for making the same ROHM AND HAAS COMPANY (US) 2015-09-08 US claimed
US-8945935-B2 Diagnosing, prognosing and monitoring multiple sclerosis TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) 2015-02-03 US claimed
US-20130034910-A1 DIAGNOSING, PROGNOSING AND MONITORING MULTIPLE SCLEROSIS RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES (IL) 2013-02-07 US claimed
US-20100292255-A1 Therapeutic Compounds and Their Use in Treating Diseases and Disorders MYRIAD PHARMACEUTICALS, INC. (US) 2010-11-18 US claimed
US-7019072-B2 Method of preparing latex for coating paper LG CHEM, LTD. (KR) 2006-03-28 US claimed
US-20030105222-A1 Method of preparing latex for coating paper LG CHEM, LTD. (KR) 2003-06-05 US claimed
WO-2002050128-A1 A METHOD OF PREPARING LATEX FOR COATING PAPER LG CHEM, LTD. (KR) 2002-06-27 WO claimed
EP-1153160-A1 CLEANER COMPOSITION AND METHOD OF USE THEREOF BetzDearborn Inc (US) 2001-11-14 EP claimed
US-6117923-A OXIDATION RESISTANCE. POLYMERIZING A NOVEL SULFUR-CONTAINING COMPOUND HAVING AN EPISULFIDE STRUCTURE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2000-09-12 US claimed
WO-2000046423-A1 CLEANER COMPOSITION AND METHOD OF USE THEREOF BETZDEARBORN INC. (US) 2000-08-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292255-A1 Therapeutic Compounds and Their Use in Treating Diseases and Disorders VHL, CLN6, CFTR CA2 3327/4885ALDH1A1 515/4885GPR84 2771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.